Patient perspectives on the use of digital medical devices and health data for AI-driven personalised medicine in Parkinson’s Disease
IntroductionParkinson’s Disease (PD) affects around 8.5 million people currently with numbers expected to rise to 12 million by 2040. PD is characterized by fluctuating motor and non-motor symptoms demanding accurate monitoring. Recent advancements in digital medical devices (DMDs) like wearables an...
Saved in:
| Main Authors: | Ivana Paccoud, Mayca Marín Valero, Laura Carrasco Marín, Noémi Bontridder, Alzhraa Ibrahim, Jüergen Winkler, Messaline Fomo, Stefano Sapienza, Fouad Khoury, Jean-Christophe Corvol, Holger Fröhlich, Jochen Klucken |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Frontiers in Neurology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2024.1453243/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Empowering Capabilities of People With Chronic Conditions Supported by Digital Health Technologies: Scoping Review
by: Messaline Fomo, et al.
Published: (2025-06-01) -
Objective monitoring of motor symptom severity and their progression in Parkinson’s disease using a digital gait device
by: Tamara Raschka, et al.
Published: (2025-07-01) -
Predicting dementia in people with Parkinson’s disease
by: Mohamed Aborageh, et al.
Published: (2025-05-01) -
Patient-centeredness Approach in Community Pharmacies: A Cross-sectional Survey
by: Mahna Ekhlasi, et al.
Published: (2024-10-01) -
Developer’s deep understanding of the diverse patient needs is critical to patient engagement with digital health technology
by: Hongnan Ye
Published: (2025-05-01)